<DOC>
<DOCNO>EP-0659748</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Substituted 1,1,-dioxo-2H-1,2-benzothiazinoylguanidines with Na+/H+-exchange inhibiting activity
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31472	A61P900	C07D21724	C07D21700	C07C31100	A61K3147	A61K3154	A61P906	A61K31472	C07D27902	C07D27900	A61K3154	A61P908	C07C31116	A61P910	C07C23300	A61P900	C07C23365	A61K3147	C07D21726	C07D21300	C07D21346	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61P	C07D	C07D	C07C	A61K	A61K	A61P	A61K	C07D	C07D	A61K	A61P	C07C	A61P	C07C	A61P	C07C	A61K	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61P9	C07D217	C07D217	C07C311	A61K31	A61K31	A61P9	A61K31	C07D279	C07D279	A61K31	A61P9	C07C311	A61P9	C07C233	A61P9	C07C233	A61K31	C07D217	C07D213	C07D213	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
There are described acylguanidines I 
<
IMAGE
>
 where X is carbonyl or sulphonyl; R(1) is H, (cyclo)alkyl, phenyl; R(2) is H, alkyl, and their pharmaceutically tolerable salts. They are obtained by reaction of a compound II 
<
IMAGE
>
  with guanidine. The compounds have no undesired salidiuretic properties, but have very good antiarrhythmic properties. As a result of inhibition of the cellular Na
<
+
>
/H
<
+
>
 exchange mechanism, they can be used for the treatment of all acute or chronic injuries induced by ischaemia.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
HOECHST AG
</APPLICANT-NAME>
<APPLICANT-NAME>
HOECHST AKTIENGESELLSCHAFT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
ALBUS UDO DR
</INVENTOR-NAME>
<INVENTOR-NAME>
KLEEMANN HEINZ-WERNER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
LANG HANS-JOCHEN DR
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHOLZ WOLFGANG DR
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHWARK JAN-ROBERT DR
</INVENTOR-NAME>
<INVENTOR-NAME>
WEICHERT ANDREAS DR
</INVENTOR-NAME>
<INVENTOR-NAME>
ALBUS, UDO, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
KLEEMANN, HEINZ-WERNER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
LANG, HANS-JOCHEN, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHOLZ, WOLFGANG, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHWARK, JAN-ROBERT, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
WEICHERT, ANDREAS, DR.
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
An acylguanidine of the formula I


in which:

R
1
is (C
3
-C
8
)-cycloalkyl or phenyl,

which is unsubstituted or substituted by
1-3 substituents from the group consisting

of F, Cl, CF
3
, CH
3
, methoxy,
hydroxyl, amino, methylamino, dimethylamino;
R
2
is H or (C
1
-C
4
)-alkyl;

and the pharmaceutically suitable salts thereof.
A compound of the formula I as claimed in claim 1,
in which the carbonyl guanidide [-CO-N=C(NH
2
)
2
] is

situated in position 7 on the particular benzene
nucleus.
A process for the preparation of a compound I as
claimed in claim 1, which comprises reacting a

compound of the formula II 


in which R
1
 and R
2
 have the meaning stated in claim
1 and L is a leaving group which can easily undergo

nucleophilic substitution and which is selected
from the group consisting of methoxy, phenoxy,

phenylthio, methylthio, 2-pyridylthio, 1-imidazolyl,
-OCOOethyl, -O-SO
2
-p-tolyl and -O-C(=N-cyclohexyl)
- (NH-cyclohexyl) with guanidine.
A compound of the formula II


in which R
1
 and R
2
 have the meaning stated in claim
1 and


L
is methoxy, phenoxy, phenylthio, methylthio,
2- pyridylthio, 1-imidazolyl, -OCOOethyl,

-O-SO
2
-p-tolyl or -O-C(=N-cyclohexyl)-(NH-cyclohexyl).
The use of a compound I as claimed in claim 1 for
the production of a medicament for the treatment of

arrhythmias.
The use of a compound I as claimed in claim 1 for
the production of a medicament for the treatment or

prophylaxis of myocardial infarct. 
The use of a compound I as claimed in claim 1 for
the production of a medicament for the treatment or

prophylaxis of angina pectoris.
The use of a compound I as claimed in claim 1 for
the production of a medicament for the treatment or

prophylaxis of ischemic states of the heart.
The use of a compound I as claimed in claim 1 for
the production of a medicament for the treatment or

prophylaxis of ischemic states of the peripheral
and central nervous system and of stroke.
The use of a compound I as claimed in claim 1 for
the production of a medicament for the treatment or

prophylaxis of ischemic states of the peripheral
organs and limbs.
The use of a compound I as claimed in claim 1 for
the production of a medicament for the treatment of

states of shock.
The use of a compound I as claimed in claim 1 for
the production of a medicament for use in surgical

operations and organ transplants.
The use of a compound I as claimed in claim 1 for
the production of a medicament for the preservation

and storage of transplants for surgical procedures.
The use of a compound I as claimed in claim 1 for
the production of a medicament for the treatment of

diseases in which cell proliferation represents a
primary or secondary cause.
A medicine which comprises an effective amount of a
compound of the formula I as claimed in claim 1 and

conventional additives.
</CLAIMS>
</TEXT>
</DOC>
